Ontex records revenue and EBITDA growth in 2024

Ontex closed the 2024 fiscal year with a 3.5% growth in revenue, totaling 1.86 billion euros, driven by a 5.7% increase in volumes. Adjusted EBITDA advanced 28% to 223 million euros, reflecting gains in competitiveness and operational efficiency.

 “We achieved key strategic milestones last year, thanks to the dedication of Ontex’s teams. With all planned strategic divestments finalized or agreed, we will be fully focused on retailer and healthcare brands by end 2025”, said Gustavo Calvo paz, CEO of Ontex. “We also achieved a major step to make our European footprint leaner, with the transformation of our Belgian operations to be finalized early 2026. These measures are necessary to continue driving our competitiveness and profitability, as we did in the last two years”, he added.

In the fourth quarter of 2024, Ontex achieved revenues of 476 million euros, up 6.6% on the same period last year, with volumes growing 9%. Adjusted EBITDA in the quarter was 57 million euros, an increase of 22% compared to 2023. The adjusted EBITDA margin rose to 11.9%, reflecting the execution of the cost transformation program.

The company also made progress on its strategic plan, finalizing the sale of operations in Turkey and consolidating its operations in Europe and North America. Net financial debt was reduced to 612 million euros, with leverage falling from 3.25x to 2.46x in the year.

For 2025, Ontex projects revenue growth of between 3% and 5%, driven by double-digit volumes in North America. Adjusted EBITDA is expected to advance between 4% and 7%, while free cash flow will remain strong, with investments in transformation reaching the final phase.